Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth

NCT04627337 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Saccharomyces Boulardii 250 MG
BEHAVIORAL: Dietary advice following a low fermentation diet

Sponsor

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno